Evidence map›Paper›PMID 24358204›Full record

ArticlePloS one2013

Polymorphisms of CYP51A1 from cholesterol synthesis: associations with birth weight and maternal lipid levels and impact on CYP51 protein structure.

Monika Lewińska, Urska Zelenko, Franci Merzel, Simona Golic Grdadolnik, Jeffrey C Murray, Damjana Rozman

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.4field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. International journal of clinical pharmacology and therapeutics · 2021
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 2 countries.

Monika LewińskaCenter for Functional Genomics and Bio-Chips, Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia.
Urska ZelenkoLaboratory of Biomolecular Structure, National Institute of Chemistry Slovenia, Ljubljana, Slovenia.
Franci MerzelLaboratory of Biomolecular Structure, National Institute of Chemistry Slovenia, Ljubljana, Slovenia.
Simona Golic GrdadolnikLaboratory of Biomolecular Structure, National Institute of Chemistry Slovenia, Ljubljana, Slovenia ; EN-FIST Centre of Excellence, Ljubljana, Slovenia.
Jeffrey C MurrayDepartment of Pediatrics, University of Iowa, Iowa City, Iowa, United States of America.
Damjana RozmanCenter for Functional Genomics and Bio-Chips, Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia.
National Institute of Chemistry · SIUniversity of Ljubljana · SIEN-FIST Centre of Excellence (Slovenia) · SIUniversity of Iowa · US

Funding

Pulmonary Toxicology Facility CoreP30ES005605 · NIEHS · UNIVERSITY OF IOWA · PI Brandi Janssen · 1990 to 2026
$40.5M
Maternal and fetal genetic factors in preterm birthR01HD052953 · NICHD · UNIVERSITY OF IOWA · PI MURRAY, JEFFREY C · 2006 to 2010
$2.8M
NICHD NIH HHS HD52953NICHD NIH HHS R01 HD052953NIEHS NIH HHS P30 ES005605
6 · The paper itself

Abstract

We investigated the housekeeping cytochrome P450 CYP51A1 encoding lanosterol 14α-demethylase from cholesterol synthesis that was so far not directly linked to human disorders. By direct sequencing of CYP51A1 in 188 women with spontaneous preterm delivery and 188 unrelated preterm infants (gestational age <37 weeks) we identified 22 variants where 10 are novel and rare. In infants there were two novel CYP51A1 variants where damaging effects of p.Tyr145Asp from the substrate recognition region, but not p.Asn193Asp, were predicted by PolyPhen2 and SIFT. This was confirmed by molecular modeling showing that Tyr145Asp substitution results in changed electrostatic potential of the CYP51 protein surface and lengthened distance to the heme which prevents hydrogen bonding. The CYP51 Tyr145Asp mutation is rare and thus very interesting for further structure/function relationship studies. From the 12 identified known variants rs6465348 was chosen for family based association studies due to its high minor allele frequency. Interestingly, this CYP51A1 common variant associates with small for gestational age weight in newborns (p = 0.028) and lower blood total cholesterol and low density lipoprotein cholesterol levels in mothers in 2nd trimester of pregnancy (p = 0.042 and p = 0.046 respectively). Our results indicate a new link between a cholesterol synthesis gene CYP51A1 and pregnancy pathologies.

Indexed as

Polymorphism, Single NucleotideBirth WeightFemaleGenetic Association StudiesHumansInfant, NewbornInfant, PrematureLipidsPregnancyProtein ConformationSterol 14-DemethylaseCYP51A1 protein, humanLipidsSterol 14-Demethylase

Identifiers

PMID24358204
PMCPMC3866192
OpenAlexW1997468540

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.